Dose Adjustments to Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures

被引：0
|
作者：
Rosenfeld, William E. [1 ]
Abou-Khalil, Bassel [2 ]
Aboumatar, Sami [3 ]
Bhatia, Perminder [4 ]
Biton, Victor [5 ]
Klein, Pavel [6 ]
Krauss, Gregory L. [7 ]
Sperling, Michael R. [8 ]
Vossler, David G. [9 ]
Wechsler, Robert [10 ]
机构：
[1] Comprehens Epilepsy Care Ctr Children & Adults, New York, NY USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Austin Epilepsy Care Ctr, Austin, TX USA
[4] Neuro Pain Med Ctr, Fresno, CA USA
[5] Arkansas Epilepsy Program, Little Rock, AR USA
[6] Mid Atlantic Epilepsy & Sleep Ctr, North Bethesda, MD USA
[7] Johns Hopkins Univ, Baltimore, MD 21218 USA
[8] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[9] Univ Washington, Sch Med, Seattle, WA 98195 USA
[10] Idaho Comprehens Epilepsy Ctr, Boise, ID USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1755
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study
    French, Jacqueline A.
    Chung, Steve S.
    Krauss, Gregory L.
    Lee, Sang Kun
    Maciejowski, Maciej
    Rosenfeld, William E.
    Sperling, Michael R.
    Kamin, Marc
    EPILEPSIA, 2021, 62 (09) : 2142 - 2150
  • [32] Long-term Efficacy and Safety of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures: Open-label Extension of a Randomized Clinical Study
    Klein, Pavel
    Krauss, Gregory
    Aboumatar, Sami
    Kamin, Marc
    NEUROLOGY, 2020, 94 (15)
  • [33] Lacosamide Monotherapy for the Treatment of Partial-Onset Seizures: Post-Hoc Analysis of Responder Rates from a Multicenter, Open-Label Extension Trial
    Vossler, David
    Wechsler, Robert
    Williams, Paulette
    Bymes, William
    Therriault, Sheila
    NEUROLOGY, 2016, 86
  • [34] Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study
    Lyu, Fangfang
    Cao, Junning
    Wang, Tingyu
    Sun, Xiuhua
    Qiu, Lihua
    Su, Hang
    Li, Zhiming
    Song, Yuqin
    Zhang, Li
    Li, Dengju
    Wu, Huijing
    Zhang, Wei
    Li, Junmin
    Zhou, Keshu
    Zhou, Hui
    Yang, Yu
    Li, Zhifeng
    Cen, Hong
    Cai, Zhen
    Zhang, Zhihui
    Fu, Weijun
    Jie, Jin
    Li, Fei
    Wu, Weixin
    Gu, Xuekui
    Zhu, Weiliang
    Liu, Lihong
    Li, Zengjun
    Yi, Shuhua
    Bao, Hanying
    Xu, Zusheng
    Qiu, Lugui
    BLOOD, 2023, 142
  • [35] Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension study
    Trinka, Eugen
    Rocamora, Rodrigo
    Chaves, Joao
    Koepp, Mathias J.
    Rueegg, Stephan
    Holtkamp, Martin
    Moreira, Joana
    Fonseca, Miguel M.
    Castilla-Fernandez, Guillermo
    Ikedo, Fabio
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16
  • [36] Post-hoc analysis of open-label extension period of study MCI186-19 in amyotrophic lateral sclerosis
    Takei, Koji
    Tsuda, Kikumi
    Takahashi, Fumihiro
    Palumb, Joseph
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 : 64 - 70
  • [37] Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study
    Ishigooka, Jun
    Inada, Ken
    Niidome, Kazunari
    Aoki, Kazuo
    Kojima, Yoshitsugu
    Iwashita, Shuichi
    Yamada, Sakiko
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (04)
  • [38] Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures
    Brandt, Christian
    Dimova, Svetlana
    Elmoufti, Sami
    Laloyaux, Cedric
    Nondonfaz, Xavier
    Klein, Pavel
    EPILEPSY & BEHAVIOR, 2023, 138
  • [39] Predictors of Response to Etanercept-Methotrexate Treatment: Post-hoc Analysis of a Randomized, Open-label Study in Latin American Patients with Rheumatoid Arthritis
    de la Vega, Maria
    Guerra Bautista, Generoso
    Xavier, Ricardo Machado
    Pacheco-Tena, Cesar
    Solano, Gaston
    Pedersen, Ronald
    Borlenghi, Cecila
    Santana, Karina
    Vlahos, Bonnie
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [40] Impact of number of lifetime antiseizure medications on 12-month effectiveness, quality of life and tolerability outcomes of adjunctive brivaracetam in patients with focal seizures: Post-hoc analysis of a real-world European study
    Leach, J.
    Kelemen, A.
    Doherty, C.
    Schulz, A. -L.
    Brock, F.
    Leunikava, I.
    Bourikas, D.
    Steinhoff, B.
    EPILEPSIA, 2022, 63 : 64 - 64
12345